Advisors Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $24.7M | Sell |
881,273
-36,540
| -4% | -$973K | 0.41% | 31 |
|
|
2025
Q4 | $22.9M | Buy |
917,813
+49,486
| +6% | +$1.25M | 0.38% | 36 |
|
|
2025
Q3 | $22.1M | Buy |
868,327
+39,989
| +5% | +$987K | 0.38% | 37 |
|
|
2025
Q2 | $20.1M | Buy |
828,338
+23,633
| +3% | +$551K | 0.36% | 38 |
|
|
2025
Q1 | $20.4M | Buy |
804,705
+56,237
| +8% | +$1.47M | 0.38% | 37 |
|
|
2024
Q4 | $19.9M | Buy |
748,468
+59,283
| +9% | +$1.61M | 0.37% | 42 |
|
|
2024
Q3 | $19.9M | Buy |
689,185
+28,704
| +4% | +$837K | 0.37% | 46 |
|
|
2024
Q2 | $18.5M | Buy |
660,481
+4,544
| +0.7% | +$125K | 0.36% | 47 |
|
|
2024
Q1 | $18.2M | Buy |
655,937
+78,352
| +14% | +$2.17M | 0.35% | 47 |
|
|
2023
Q4 | $16.6M | Buy |
577,585
+13,008
| +2% | +$393K | 0.34% | 53 |
|
|
2023
Q3 | $18.7M | Buy |
564,577
+15,507
| +3% | +$548K | 0.4% | 43 |
|
|
2023
Q2 | $20.1M | Buy |
549,070
+25,522
| +5% | +$993K | 0.41% | 45 |
|
|
2023
Q1 | $21.4M | Sell |
523,548
-10,623
| -2% | -$459K | 0.43% | 41 |
|
|
2022
Q4 | $27.4M | Buy |
534,171
+16,723
| +3% | +$802K | 0.56% | 29 |
|
|
2022
Q3 | $22.6M | Sell |
517,448
-21,648
| -4% | -$1.05M | 0.48% | 35 |
|
|
2022
Q2 | $28.3M | Sell |
539,096
-27,082
| -5% | -$1.38M | 0.54% | 29 |
|
|
2022
Q1 | $29.3M | Buy |
566,178
+5,289
| +0.9% | +$274K | 0.45% | 32 |
|
|
2021
Q4 | $33.1M | Sell |
560,889
-20,238
| -3% | -$1M | 0.47% | 32 |
|
|
2021
Q3 | $25M | Sell |
581,127
-88,404
| -13% | -$3.92M | 0.38% | 39 |
|
|
2021
Q2 | $26.2M | Sell |
669,531
-151,995
| -19% | -$5.91M | 0.39% | 38 |
|
|
2021
Q1 | $29.8M | Sell |
821,526
-104,357
| -11% | -$3.71M | 0.46% | 30 |
|
|
2020
Q4 | $34.1M | Sell |
925,883
-240,795
| -21% | -$8.83M | 0.56% | 25 |
|
|
2020
Q3 | $40.6M | Sell |
1,166,678
-64,964
| -5% | -$2.28M | 0.75% | 16 |
|
|
2020
Q2 | $38.2M | Buy |
1,231,642
+23,616
| +2% | +$802K | 0.74% | 16 |
|
|
2020
Q1 | $37.4M | Buy |
1,208,026
+95,884
| +9% | +$3.27M | 0.89% | 14 |
|
|
2019
Q4 | $41.3M | Buy |
1,112,142
+5,929
| +0.5% | +$211K | 0.72% | 15 |
|
|
2019
Q3 | $37.7M | Sell |
1,106,213
-92,188
| -8% | -$3.35M | 0.69% | 17 |
|
|
2019
Q2 | $49.3M | Sell |
1,198,401
-137,683
| -10% | -$5.47M | 0.89% | 9 |
|
|
2019
Q1 | $53.8M | Sell |
1,336,084
-153,244
| -10% | -$6.14M | 0.96% | 8 |
|
|
2018
Q4 | $61.7M | Sell |
1,489,328
-206,850
| -12% | -$8.59M | 1.24% | 6 |
|
|
2018
Q3 | $70.9M | Sell |
1,696,178
-34,055
| -2% | -$1.31M | 1.16% | 5 |
|
|
2018
Q2 | $59.6M | Sell |
1,730,233
-123,535
| -7% | -$4.22M | 1.01% | 7 |
|
|
2018
Q1 | $63.9M | Sell |
1,853,768
-18,724
| -1% | -$644K | 1.07% | 6 |
|
|
2017
Q4 | $64.3M | Sell |
1,872,492
-43,204
| -2% | -$1.47M | 1.06% | 5 |
|
|
2017
Q3 | $64.9M | Sell |
1,915,696
-53,095
| -3% | -$1.71M | 1.09% | 1 |
|
|
2017
Q2 | $62.7M | Buy |
1,968,791
+115,390
| +6% | +$3.64M | 1.05% | 1 |
|
|
2017
Q1 | $60.2M | Buy |
1,853,401
+35,948
| +2% | +$1.13M | 1.01% | 1 |
|
|
2016
Q4 | $56M | Buy |
1,817,453
+39,869
| +2% | +$1.22M | 0.93% | 2 |
|
|
2016
Q3 | $57.1M | Buy |
1,777,584
+40,135
| +2% | +$1.34M | 0.94% | 2 |
|
|
2016
Q2 | $58M | Sell |
1,737,449
-118,550
| -6% | -$3.78M | 0.94% | 2 |
|
|
2016
Q1 | $52.2M | Sell |
1,855,999
-222,125
| -11% | -$6.34M | 0.87% | 3 |
|
|
2015
Q4 | $63.6M | Sell |
2,078,124
-219,412
| -10% | -$6.9M | 1.01% | 1 |
|
|
2015
Q3 | $68.5M | Sell |
2,297,536
-207,242
| -8% | -$6.64M | 1.09% | 1 |
|
|
2015
Q2 | $79.7M | Buy |
2,504,778
+209,428
| +9% | +$6.83M | 1.09% | 1 |
|
|
2015
Q1 | $75.8M | Buy |
2,295,350
+74,731
| +3% | +$2.38M | 1.01% | 1 |
|
|
2014
Q4 | $65.6M | Buy |
2,220,619
+72,448
| +3% | +$2.08M | 0.88% | 5 |
|
|
2014
Q3 | $60.3M | Buy |
2,148,171
+143,577
| +7% | +$4.03M | 0.83% | 7 |
|
|
2014
Q2 | $56.4M | Buy |
2,004,594
+21,981
| +1% | +$627K | 0.78% | 7 |
|
|
2014
Q1 | $60.4M | Buy |
1,982,613
+174,736
| +10% | +$5.21M | 0.92% | 6 |
|
|
2013
Q4 | $52.5M | Buy |
1,807,877
+243,317
| +16% | +$7.08M | 0.85% | 9 |
|
|
2013
Q3 | $42.6M | Buy |
1,564,560
+78,560
| +5% | +$2.14M | 0.76% | 11 |
|
|
2013
Q2 | $39.5M | Buy |
+1,486,000
| New | +$41.1M | 0.75% | 8 |
|
Other funds holding PFE
VCM
VPM
Advisors Asset Management's PFE Position: Q1 2026 in Review
Advisors Asset Management reduced its Pfizer (PFE) stake by 4% in Q1 2026, selling an estimated $973K and leaving 881,273 shares worth $24.7M. The position accounts for 0.41% of the portfolio, ranked #31.
Advisors Asset Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $79.7M in Q2 2015. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Advisors Asset Management held 881,273 shares of Pfizer worth $24.7M as of Q1 2026.
- Advisors Asset Management sold 36,540 Pfizer shares in Q1 2026, an estimated $973K.
- Pfizer made up 0.41% of Advisors Asset Management's portfolio in Q1 2026, its #31 holding.
- Advisors Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Advisors Asset Management's Pfizer position peaked at $79.7M in Q2 2015.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Advisors Asset Management's 13F filing for Q1 2026, filed 15 May 2026.